Rezon Bio announces that its Warsaw-Duchnice facility has received approval from the U.S. Food and Drug Administration (FDA) for the commercial manufacturing of a biosimilar. This milestone represents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results